FdaApplication
ANDA 210835
Identifiers
- fda_app_no: ANDA210835
Properties
| Property | Value |
|---|---|
| applicant_name | XIROMED PHARMA ESPANA SL |
| application_type | ANDA |
| approval_date | 2020-04-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TESTOSTERONE | TESTOSTERONE | 1.62% (20.25MG/1.25GM ACTUATION) | GEL, METERED;TRANSDERMAL |
1 product